Adrenoceptor activating & Other Sympathomimetic drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)

Slides:



Advertisements
Similar presentations
Catecholamine Agonists and Antagonists. Need-to-know Drugs Norepinephrine Norepinephrine Alpha 1 & 2 and Beta 1 agonist Alpha 1 & 2 and Beta 1 agonist.
Advertisements

Sympathetic Drugs. Stress and The Adrenal Glands.
PHARMACOLOGY OF SNS.
Drugs Affecting Peripheral Nervous System #2. Fight or Flight versus the Parasympathetic Pig.
Pharmacology-1 PHL 211 Fourteenth Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacology-1 PHL 211 Thirteenth Lecture By Abdelkader Ashour, Ph.D. Phone:
Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology
Adrenergic agonists Samuel Aguazim (MD).
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
SYMPATHOMIMETIC DRUGS
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics According to spectrum of action According to chemistry According to mode.
Autonomic Nervous System Drugs
Chapter 5 Autonomic Drugs.
Drugs Affecting the Sympathetic Nervous System
ADRENERGIC ANTAGONITS
Sympathomimetic Drugs
Autonomic Nervous System
Adrenergic Agonists Dr. Asmah Nasser, M.D..
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic Drugs.
ADRENERGIC RECEPTORS AND DRUGS
Adrenergic antagonist sympatholytic
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Sympathomimetics (continue)
SYMPATHOMIMETIC DRUGS
Adrenergic agonists Samuel Aguazim (MD).
Sympathomimetics Ed Bilsky, Ph.D. Department of Pharmacology University of New England Phone , x2707
AUTONOMIC SYSTEMS AND DRUGS-2
Autonomic drugs: Adrenoceptor Agonists and Sympathomimetics
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
1 A N S  NERVOUS SYSTEM  PNS CNS   EFFERENT AFFERENT   ANS SOMATIC  ENTERIC  PARASYMPATHETIC  SYMPATHETIC.
Adrenergic Agonists Prof. A. Alhaider. Tyrosine Dopa DA NE Na COMT NET Ca Norepinephrine (NE) SYNTHESIS STORAGE RELEASE ACTION REUPTAKE DEGRADE POSTGANGLIONIC.
AUTONOMICS MA. JANETTH B. SERRANO, M.D. DPBA. Site and Mode of Action: Site and Mode of Action: 1. Direct Acting –Epinephrine- Dobutamine –Phenylephrine-
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Sympathomimetic Agents
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
AUTONOMIC NERVOUS SYSTEM LECTURE 6 PHARMACOLOGY. Autonomic Pharmacology Autonomic Nervous System – This system is divided into two separate systems. –
23 كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، 1623 كانون الثاني، كانون الثاني، كانون الثاني،
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
Sympathomimetics Review 28 February :25 PM.
Sympathetic Nervous System.
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
SYMPATHOMIMETIC AGENTS
Adrenergic Drugs.
Adrenergic Agonists.
Dr. Rashidi Nooshabadi 11/11/2015. Smooth muscle of vessels residing in skeletal muscle Dr.Rashidi Nooshabadi 11/11/2015.
Department of Pharmacology
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
ADRENERGIC MEDICATIONS (sympathomimetic drugs)
Adrenergic agonist: PHARMACOLOGY OF SNS.
Adrenergic Agonists Produce their effects by activating adrenergic receptors Adrenergic receptors are Alpha 1 Alpha 2 Beta 1 Beta 2 Dopamine.
Pharmacology of the nervous system
Pharmacological actions of cathecholamines
Type of adrenergic receptor
HuBio 543 September 25, 2007 Neil M. Nathanson K-536A, HSB
Sympathomimetics Domina Petric, MD.
School of Pharmacy, University of Nizwa
Sympathomimetic drugs
Adrenergic agonists.
جامعة الملك فيصل كلية الصيدلة الإكلينيكية College of Clinical PharmacyKing Faisal University جامعة الملك فيصل كلية الصيدلة الإكلينيكية College of Clinical.
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic agonists and antagonists
Adrenergic agonists ILOS
Chaper 20 Adrenoceptor Antagonists
Presentation transcript:

Adrenoceptor activating & Other Sympathomimetic drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)

Objectives o มีความรู้ความเข้าใจถึง Adrenoceptor และ Molecular mechanism ของการกระตุ้น adrenoceptor o มีความรู้ความเข้าใจถึงเภสัช วิทยา กลไกการออกฤทธิ์ เภสัช จลนศาสตร์ การใช้ประโยชน์ ทางคลินิก อาการไม่พึงประสงค์ ข้อควรระวังการใช้ยาที่ออกฤทธิ์ กระตุ้นระบบประสาทซิมพาเท ติก ทั้งชนิด direct acting และ indirect acting agents

Sympathetic nervous system CVS & Response to stress Essential control of CVS & Response to stress Neurotransmitters = Norepinephrine (NE) Adrenal medulla release NE & Epinephrine (Epi) … “ Hormone ” Act on RC called “ Adrenoceptor ” “ Sympathomimetic drugs (agents) ” Drugs causing sympathetic NS like action …. “ Sympathomimetic drugs (agents) ” Mimic = Like

The mode & spectrum of action of sympathomimetic drugs Direct Direct acting sympathomimetic drugs Binding to adrenoceptor >>> Adrenoceptor agonist Indirect Indirect acting sympathomimetic drugs Increase NE at synaptic cleft Replacement of NE at vesicle Uptake via uptake 1 into nerve terminal Increase NE release from vesicle Amphetamine, Tyramine, Ephedrine Inhibit NE reuptake Inhibit uptake 1 action Also inhibit action of the above group Cocaine, Tricyclic antidepressants (TCA)

Basic Pharmacology Adrenoceptor Beta (  )-adrenoceptor  1,  2,  3 adrenoceptor  1 Affinity … NE = Epi  2 Affinity … Epi >> NE Alpha (  )-adrenoceptor  1,  2 adrenoceptor  -1A,  -1B,  -1D  -2A,  -2B,  -2C  1 antagonist … Prazosin  2 antagonist … Yohimbine  1 &  2 antagonist (non-selective) … Dihydroergotamine Difference of adrenoceptor Affinity of selected agents Affinity of selected agents Molecular … Genes Molecular … Genes

Dopamine receptor Dopamine (DA) = Catecholamine Bind to Dopamine receptor & Adrenoceptor Important in CNS function & disease Psychosis … over DA Parkinson ’ s disease … lack of DA Some effects on splanchnic & renal vascular D1-like receptor D1-, D5-receptor D2-like receptor D2-, D3-, D4-receptor

Receptor selectivity

cAMP-dep. Protein kinase Gs Gi

Distribution of adrenoceptor subtypes TypeTissueActions Alpha1Most vascular smooth muscle (innervated) Contraction Pupillary dilator muscleContraction (dilates pupil) Pilomotor smooth muscleErects hair ProstateContraction HeartIncreases force of contraction Alpha2Postsynaptic CNS adrenoceptorsProbably multiple PlateletsAggregation Adrenergic and cholinergic nerve terminals Inhibition of transmitter release Some vascular smooth muscleContraction Fat cellsInhibition of lipolysis

Beta1HeartIncreases force and rate of contraction Beta2Respiratory, uterine, and vascular smooth muscle Promotes smooth muscle relaxation Skeletal musclePromotes potassium uptake Human liverActivates glycogenolysis Beta3Fat cellsActivates lipolysis D1Smooth muscleDilates renal blood vessels D2Nerve endingsModulates transmitter release

Central Nervous System (CNS) Catecholamine can not penetrate into CNS Amphetamine, Cocaine Non-catecholamine can penetrate into CNS … Amphetamine, Cocaine Alertness, Nervousness, Increased concentration of work, Insomnia, Euphoria, Anorexia, Paranoid Drug abuse Dopamine-mediated … increase pleasure … Drug addiction … Drug abuse

Clinical Pharmacology Factors considered before sympathomimetic use Factors considered before sympathomimetic use Intrinsic activity Receptor selectivity Duration of action Route of administration Bioavailability ADRs (esp. CVS)

Clinical uses H ypotension Shock Decreased local blood flow Decongestion Asthma Anaphylaxis Glaucoma Delay of labour CNS disorder>>> attention deficit, narcolepsy Others … Drug craving, hot flush

Toxicity of sympathomimetics CVS CVS Hypertension (hypertensive crisis) … cerebral hemorrhage, pulmonary edema, increase heart work load … angina, myocardial infarction (MI) Sinus tachycardia, Serious ventricular arrhythmia Use with caution in elderly, hypertensive patients, coronary artery disease patients Antagonised by Specific adrenoceptor antagonist CNS CNS … esp Amphetamine Restlessness, tremor, insomnia, anxiety, paranoid Cocaine may worsen convulsion or cerebral hemorrhage

Dobutamine HCl (Dobutrex ® )Vial 250 mg/ 20 ml Dopamine HCl (Dopaminex ® )Amp 50 mg/ 5ml, 200 mg/ 10 ml, 250 mg/ 10 ml Isoproterenol (Isuprel ® )Amp 0.2 mg/ ml Adrenaline (Epinephrine)Amp 1 mg/ ml Brimonidine (Alphagan ® )Ophth soln 0.2% Metaraminol bitartrate (Aramine ® )Vial 10 mg/ ml Methylphenidate (Rubifen ® )Tab 10 mg [children w/ attention def] Midodrine (Gutron ® )Tab 2.5 mg Naphazoline (Albalon ® )Ophth soln 0.1% Oxymetazoline (Iliadin ® )Nasal drop 0.025%, nasal spray 0.05% Phenylephrine [combined] Phenylpropanolamine [combined] Pseudoephedrine [combined] Norepinephrine [combined] Xylometazoline (Otrivin®)Metered dose nasal spray 0.1% Example of sympathomimetic drugs